Understanding Adult ADHD Treatment Options: A Patient Guide
- Kate Organ
- Jul 29
- 4 min read
What is ADHD?
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition characterised by persistent patterns of inattention, impulsivity, and/or hyperactivity that interfere with daily functioning. Although often diagnosed in childhood, ADHD frequently continues into adulthood, affecting relationships, employment, self-esteem, and mental health.
ADHD is estimated to affect approximately 2.5–4% of adults worldwide (Simon et al., 2009; Fayyad et al., 2007).
Core Symptoms of Adult ADHD:
Difficulty sustaining attention on tasks
Poor organisational skills
Impulsivity (interrupting, risk-taking)
Restlessness or internal hyperactivity
Forgetfulness in daily activities
Difficulty completing tasks
ADHD in adults often presents differently than in children. Hyperactivity may lessen with age, while executive function challenges (e.g. planning, prioritising, emotional regulation) become more prominent.
Types of ADHD
According to DSM-5 criteria (American Psychiatric Association, 2013), ADHD is categorised into three presentations:
Predominantly Inattentive Presentation
Difficulty sustaining attention
Easily distracted
Often disorganised or forgetful
Predominantly Hyperactive-Impulsive Presentation
Restlessness or fidgeting
Talking excessively
Acting without thinking
Combined Presentation
Features of both inattention and hyperactivity-impulsivity
The presentation can change over time. A full clinical assessment, often including structured interviews (e.g. DIVA-5), is required for diagnosis.

Treatment Options for Adults with ADHD
ADHD treatment is multimodal—usually combining medication with psychological interventions, lifestyle changes, and support.
NICE Guidelines (NG87, 2018) recommend:
Medication as first-line treatment for adults with moderate to severe impairment
Cognitive Behavioural Therapy (CBT) for adults who decline or cannot tolerate medication
Psychoeducation to promote understanding and self-management
Benefits of ADHD Medication
ADHD medication is clinically proven to reduce core symptoms and improve functioning. Studies show that medication can lead to:
Improved attention and focus
Reduced impulsivity and emotional reactivity
Better task initiation and completion
Improved quality of life
Response rates are high, with around 70% of adults responding to stimulants and 50–60% to non-stimulants (Bolea-Alamañac et al., 2014).
How ADHD Medications Work
ADHD is associated with altered dopamine and norepinephrine signalling, especially in the prefrontal cortex—an area linked to attention, motivation, and decision-making.
Medications improve symptoms by increasing the availability of these neurotransmitters, enhancing signal transmission in brain regions involved in executive function and self-regulation.
Types of ADHD Medication
ADHD medications are divided into two main categories:
1. Stimulants (First-Line Treatment)
Stimulants are fast-acting and have the strongest evidence base.
Methylphenidate-based: Ritalin®, Concerta XL®, Medikinet XL®
Lisdexamfetamine (Elvanse®)
Dexamfetamine
Stimulants increase dopamine and norepinephrine by inhibiting reuptake and stimulating release. They are usually well-tolerated and available in short- and long-acting formulations.
2. Non-Stimulants
These may be used when stimulants are not tolerated or contraindicated.
Atomoxetine (Strattera®): a selective norepinephrine reuptake inhibitor
Guanfacine: occasionally used off-label in adults
Certain antidepressants (e.g. bupropion, venlafaxine) may be used off-label in some cases
Non-stimulants may take 2–6 weeks to reach full effect and tend to have a more gradual onset.
What to Expect When Taking ADHD Medication
Titration Phase
Begins with a low dose
Gradually increased over weeks to find the most effective dose with the fewest side effects
Monitoring of blood pressure, heart rate, sleep, appetite, and mood is essential
Maintenance Phase
Regular reviews (every 6–12 months)
Dose adjustments may be needed if symptoms return or circumstances change
Monitoring Requirements
According to NICE NG87:
Baseline cardiovascular assessment (BP, pulse, history)
Ongoing monitoring of weight, mood, and adverse effects
Specialist review annually (minimum)
Common Side Effects
Side effects vary by individual and medication but can include:
Side Effect | Notes |
Loss of appetite | Often dose-related; monitor weight |
Insomnia | May resolve; consider dosing time |
Headache | Usually transient |
Dry mouth | Common but manageable |
Irritability or anxiety | May need dose adjustment or medication change |
Increased heart rate/BP | Requires regular monitoring |
Most side effects improve over time, but persistent issues should be discussed with your prescriber.
Medication Breaks: Are They Necessary?
Some adults choose to take planned breaks (e.g. weekends or holidays) from stimulant medication. This may be considered when:
Appetite or sleep issues are significant
Assessing whether medication is still needed
Reducing side effects or building tolerance
However, medication breaks are not recommended routinely in adults. Many people find their symptoms return quickly. Discuss any break with your prescribing clinician to ensure it’s safe and appropriate.
Other Support Options
While medication is often central, non-pharmacological interventions are also key:
Cognitive Behavioural Therapy (CBT) for ADHD
Executive functioning coaching or occupational therapy
Sleep and time-management strategies
Psychoeducation for individuals and families
Peer support groups (e.g. ADHD UK, ADDISS)
Combining medication with psychological support often leads to the best long-term outcomes.
Conclusion
ADHD in adults is a common, treatable condition. Medication can significantly improve quality of life, focus, and emotional regulation. With the right combination of treatment and support, many adults with ADHD thrive in their careers, relationships, and personal goals.
If you suspect you may have ADHD, or if you’re looking to explore treatment, speak to your GP or a qualified clinician.
Key References:
National Institute for Health and Care Excellence (NICE). (2018). Attention deficit hyperactivity disorder: diagnosis and management (NG87). https://www.nice.org.uk/guidance/ng87
Bolea-Alamañac B et al. (2014). Evidence-based guidelines for the pharmacological management of adult ADHD. J Child Psychol Psychiatry, 55(1):3-15.
Simon V et al. (2009). Prevalence and correlates of adult attention-deficit hyperactivity disorder. JAMA, 301(2), 201–214.
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.)
Fayyad J et al. (2007). Cross-national prevalence and correlates of adult ADHD. Br J Psychiatry, 190:402–409